Saturday, June 13, 2026
🇺🇸 FDA

pharma · Advanced Solid Tumor · Chronic Lymphocytic Leukemia

BEONE MEDICINES AUS

BEONE MEDICINES AUS PTY LTD

BEONE MEDICINES AUS clinical programs — 122 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

Website Investor relations
Cambridge, USA HQ
2010 Founded
3,177 Employees
TGA registrant Type
Company details
Status
Public
HQ
Cambridge, USA
Founded
2010
Employees
3,177
Programs
122
Drugs
63
Patents
0
Official website ↗ All projects Drug pipeline News & analysis

Recent coverage

View all news & analysis →
Intelligence · Clinical Programs

BEONE MEDICINES AUS projects

122 ClinicalTrials.gov programs sponsored by BEONE MEDICINES AUS.

BEONE MEDICINES AUS has 122 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

All phases Phase III Phase II Phase I NDA / BLA filed Approved programs

122 programs

Clinical programs

Page 2 of 3

  1. Gimistotug

    BEONE MEDICINES AUS PTY LTD

    Non-Small Cell Lung Cancer

    phase 2 small molecule completed

    1 trial

  2. LBL-007

    BEONE MEDICINES AUS PTY LTD

    Esophageal Cancer

    phase 2 small molecule active

    1 trial

  3. PD-1/PD-L1 inhibitors

    BEONE MEDICINES AUS PTY LTD

    Borderline Resectable Carcinoma

    phase 2 small molecule active

    1 trial

  4. Rituximab

    BEONE MEDICINES AUS PTY LTD

    Chronic Lymphocytic Leukemia

    phase 2 mab active

    1 trial

  5. Sonrotoclax

    BEONE MEDICINES AUS PTY LTD

    Relapsed/Refractory Multiple Myeloma

    phase 2 small molecule active

    1 trial

  6. Sonrotoclax

    BEONE MEDICINES AUS PTY LTD

    Waldenstrom Macroglobulinemia

    phase 2 small molecule active

    1 trial

  7. Surzebiclimab

    BEONE MEDICINES AUS PTY LTD

    Locally Advanced or Metastatic Solid Tumors for Phase 1, Dose Escalation and Phase 2 Safety Lead-in

    phase 2 small molecule completed

    1 trial

  8. Tislelizumab

    BEONE MEDICINES AUS PTY LTD

    Colorectal Cancer

    phase 2 small molecule completed

    1 trial

  9. Tislelizumab

    BEONE MEDICINES AUS PTY LTD

    Gastroesophageal Adenocarcinoma

    phase 2 small molecule active

    1 trial

  10. Tislelizumab

    BEONE MEDICINES AUS PTY LTD

    Advanced Unresectable Gastric Adenocarcinoma

    phase 2 small molecule active

    1 trial

  11. Tislelizumab

    BEONE MEDICINES AUS PTY LTD

    Resectable Esophageal Squamous Cell Carcinoma

    phase 2 small molecule completed

    1 trial

  12. Tislelizumab (BGB-A317)

    BEONE MEDICINES AUS PTY LTD

    MSI-H/dMMR Solid Tumors

    phase 2 small molecule active

    1 trial

  13. Tunlametinib+PD-1 mAb

    BEONE MEDICINES AUS PTY LTD

    Gastric Adenocarcinoma

    phase 2 small molecule active

    1 trial

  14. ZW25 (Zanidatamab)

    BEONE MEDICINES AUS PTY LTD

    HER2-amplified Biliary Tract Cancers

    phase 2 small molecule completed

    1 trial

  15. Zanubrutinib

    BEONE MEDICINES AUS PTY LTD

    Mantle Cell Lymphoma

    phase 2 small molecule active

    1 trial

  16. Zanubrutinib

    BEONE MEDICINES AUS PTY LTD

    Relapsed/Refractory Follicular Non-Hodgkin Lymphoma

    phase 2 small molecule completed

    1 trial

  17. Zanubrutinib

    BEONE MEDICINES AUS PTY LTD

    Relapsed Diffuse Large B-cell Lymphoma

    phase 2 small molecule completed

    1 trial

  18. Zanubrutinib

    BEONE MEDICINES AUS PTY LTD

    Mature B-cell Malignancies

    phase 2 small molecule completed

    1 trial

  19. Zanubrutinib

    BEONE MEDICINES AUS PTY LTD

    Follicular Lymphoma

    phase 2 small molecule active

    1 trial

  20. Zanubrutinib

    BEONE MEDICINES AUS PTY LTD

    Diffuse Large B-cell Lymphoma (DLBCL)

    phase 2 small molecule active

    1 trial

  21. Zanubrutinib

    BEONE MEDICINES AUS PTY LTD

    Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

    phase 2 small molecule completed

    1 trial

  22. Zanubrutinib

    BEONE MEDICINES AUS PTY LTD

    Chronic Lymphocytic Leukemia (CLL)

    phase 2 small molecule active

    1 trial

  23. A Phase 1a/1b for Advanced, metastatic or unresec…

    BEONE MEDICINES AUS PTY LTD

    Advanced, metastatic or unresectable solid tumors

    phase 1 other active

    1 trial

  24. A Phase 1a/b Study Investigating the Safety for Advanced, or metastatic solid t…

    BEONE MEDICINES AUS PTY LTD

    Advanced, or metastatic solid tumors with methylthioadenosine phosphorylase (MTAP) homozygous deletion and/or lost MTAP protein expression

    phase 1 other active

    1 trial

  25. AMG 509

    BEONE MEDICINES AUS PTY LTD

    Prostate Cancer

    phase 1 small molecule active

    1 trial

  26. BG-60366

    BEONE MEDICINES AUS PTY LTD

    Non-Small Cell Lung Cancer

    phase 1 small molecule terminated

    1 trial

  27. BG-60366-101

    BEONE MEDICINES AUS PTY LTD

    EGFR-Mutant Non-Small Cell Lung Cancer

    phase 1 other active

    1 trial

  28. BG-68501

    BEONE MEDICINES AUS PTY LTD

    Breast Cancer

    phase 1 small molecule active

    1 trial

  29. BG-71332

    BEONE MEDICINES AUS PTY LTD

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  30. BG-75098

    BEONE MEDICINES AUS PTY LTD

    Advanced Solid Tumor

    phase 1 small molecule active

    1 trial

  31. BG-75202

    BEONE MEDICINES AUS PTY LTD

    Breast Cancer

    phase 1 small molecule active

    1 trial

  32. BG-75202-101

    BEONE MEDICINES AUS PTY LTD

    Advanced and Metastatic Solid tumors

    phase 1 other active

    1 trial

  33. BG-89894

    BEONE MEDICINES AUS PTY LTD

    Advanced or Metastatic MTAP-deleted Solid Tumors

    phase 1 small molecule terminated

    1 trial

  34. BG-A3004

    BEONE MEDICINES AUS PTY LTD

    Skin Diseases

    phase 1 mab active

    1 trial

  35. BG-C0902

    BEONE MEDICINES AUS PTY LTD

    Solid Tumors

    phase 1 small molecule active

    1 trial

  36. BG-C0979

    BEONE MEDICINES AUS PTY LTD

    Advanced Solid Tumor

    phase 1 small molecule active

    1 trial

  37. BG-C0979-101

    BEONE MEDICINES AUS PTY LTD

    Advanced Solid Tumors

    phase 1 other active

    1 trial

  38. BG-C137

    BEONE MEDICINES AUS PTY LTD

    Advanced Solid Tumor

    phase 1 small molecule active

    1 trial

  39. BG-C477

    BEONE MEDICINES AUS PTY LTD

    Advanced Solid Tumors

    phase 1 small molecule active

    1 trial

  40. BG-C9074

    BEONE MEDICINES AUS PTY LTD

    Advanced Solid Tumor

    phase 1 small molecule active

    1 trial

  41. BGB-11417

    BEONE MEDICINES AUS PTY LTD

    Mature B-cell Malignancies

    phase 1 small molecule active

    1 trial

  42. BGB-15025

    BEONE MEDICINES AUS PTY LTD

    Advanced Solid Tumor

    phase 1 small molecule active

    1 trial

  43. BGB-16673

    BEONE MEDICINES AUS PTY LTD

    Chronic Spontaneous Urticaria

    phase 1 small molecule active

    1 trial

  44. BGB-16673

    BEONE MEDICINES AUS PTY LTD

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  45. BGB-21447

    BEONE MEDICINES AUS PTY LTD

    Relapsed Non-Hodgkin Lymphoma

    phase 1 small molecule active

    1 trial

  46. BGB-21447

    BEONE MEDICINES AUS PTY LTD

    Hormone-receptor-positive Breast Cancer

    phase 1 small molecule active

    1 trial

  47. BGB-24714

    BEONE MEDICINES AUS PTY LTD

    Solid Tumor, Adult

    phase 1 small molecule terminated

    1 trial

  48. BGB-26808

    BEONE MEDICINES AUS PTY LTD

    Advanced Solid Tumor

    phase 1 small molecule active

    1 trial

Frequently asked questions

How many clinical projects does BEONE MEDICINES AUS have?

122 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.